Takotsubo Cardiomyopathy
Summary
Takotsubo cardiomyopathy (also called "broken heart syndrome" or stress cardiomyopathy) is a temporary weakening of the heart muscle, usually triggered by severe emotional or physical stress. Think of your heart as a pump—when under extreme stress, part of the heart muscle temporarily stops contracting properly, causing the heart to balloon out (especially the apex, giving it a characteristic "octopus pot" or "takotsubo" shape on imaging). This condition mimics a heart attack (chest pain, ECG changes, elevated cardiac enzymes) but is caused by stress hormones rather than blocked arteries. It's more common in postmenopausal women and usually resolves completely within weeks to months. The key to management is recognizing it (especially in the context of recent stress), providing supportive care (treat heart failure if present, manage complications), and monitoring for recovery. Most patients recover completely, but complications (heart failure, arrhythmias, thrombus formation) can occur and need treatment.
Key Facts
- Definition: Temporary stress-induced cardiomyopathy with characteristic apical ballooning
- Incidence: ~1-2% of patients presenting with suspected ACS
- Mortality: Low (1-5%) unless complications
- Peak age: Postmenopausal women (60-75 years)
- Critical feature: Stress trigger, mimics ACS, usually resolves
- Key investigation: Echocardiography, coronary angiography (to rule out ACS)
- First-line treatment: Supportive care, treat heart failure, prevent complications
Clinical Pearls
"Think of it in postmenopausal women with stress" — Takotsubo is most common in postmenopausal women who have had recent severe emotional or physical stress. Always consider it in this population.
"Mimics heart attack but no blocked arteries" — Patients present like a heart attack (chest pain, ECG changes, elevated troponin), but coronary angiography shows no significant blockages. The heart muscle is stunned, not infarcted.
"Usually resolves completely" — Unlike a heart attack, takotsubo usually resolves completely within weeks to months. The heart muscle recovers fully in most cases.
"Complications can be serious" — Heart failure, cardiogenic shock, arrhythmias, and thrombus formation can occur. Monitor closely and treat complications.
Why This Matters Clinically
Takotsubo cardiomyopathy is an important mimic of acute coronary syndrome that requires different management. Early recognition (especially in postmenopausal women with stress) can prevent unnecessary interventions and ensure appropriate supportive care. Most patients recover completely, but complications need prompt treatment. This is a condition that cardiologists and emergency clinicians need to recognize.
Incidence & Prevalence
- Overall: ~1-2% of patients presenting with suspected ACS
- Trend: Increasing recognition (previously underdiagnosed)
- Peak age: Postmenopausal women (60-75 years)
Demographics
| Factor | Details |
|---|---|
| Age | Peak 60-75 years (postmenopausal women) |
| Sex | Strong female predominance (90% women) |
| Ethnicity | No significant variation |
| Geography | Worldwide, no significant variation |
| Setting | Emergency departments, cardiology units |
Risk Factors
Non-Modifiable:
- Female sex (especially postmenopausal)
- Age (older = more common)
Modifiable:
| Risk Factor | Relative Risk | Mechanism |
|---|---|---|
| Severe emotional stress | 5-10x | Triggers catecholamine surge |
| Severe physical stress | 3-5x | Triggers catecholamine surge |
| Underlying psychiatric conditions | 2-3x | May increase vulnerability |
Common Triggers
| Trigger | Frequency | Typical Patient |
|---|---|---|
| Emotional stress | 30-40% | Grief, relationship problems, work stress |
| Physical stress | 20-30% | Surgery, medical procedures, illness |
| Combined | 20-30% | Both emotional and physical |
| No obvious trigger | 10-20% | Spontaneous |
The Stress Response Mechanism
Step 1: Severe Stress
- Emotional or physical stress: Severe stressor
- Catecholamine surge: Massive release of stress hormones (adrenaline, noradrenaline)
- Result: High levels of catecholamines
Step 2: Myocardial Stunning
- Direct toxicity: High catecholamines directly toxic to heart muscle
- Microvascular dysfunction: Causes microvascular spasm
- Result: Heart muscle stunned (temporarily stops contracting)
Step 3: Apical Ballooning
- Apex affected: Apex most vulnerable (high density of catecholamine receptors)
- Ballooning: Apex balloons out (characteristic shape)
- Result: Characteristic "takotsubo" appearance
Step 4: Clinical Manifestation
- Chest pain: Like heart attack
- Heart failure: If severe
- ECG changes: ST elevation, T wave changes
- Troponin elevation: Muscle damage
Step 5: Recovery
- Reversible: Heart muscle recovers
- Resolution: Usually resolves completely (weeks to months)
- Result: Full recovery in most cases
Classification by Pattern
| Pattern | Definition | Clinical Features |
|---|---|---|
| Apical | Apex balloons (classic) | Most common (80%) |
| Mid-ventricular | Mid-ventricle affected | Less common (15%) |
| Basal | Base affected | Rare (5%) |
| Focal | Focal area affected | Rare |
Anatomical Considerations
Heart Anatomy:
- Apex: Tip of heart (most commonly affected)
- Base: Top of heart
- Ventricles: Pumping chambers
Why Apex is Vulnerable:
- High catecholamine receptors: More receptors in apex
- Blood supply: May be more vulnerable to microvascular dysfunction
Symptoms: The Patient's Story
Typical Presentation:
History:
Signs: What You See
Vital Signs (May Be Abnormal):
| Sign | Finding | Significance |
|---|---|---|
| Temperature | Usually normal | Usually normal |
| Heart rate | May be high (stress, heart failure) | Tachycardia |
| Blood pressure | May be low (heart failure) | Hypotension |
| Respiratory rate | May be high (heart failure) | Tachypnea |
General Appearance:
Cardiovascular Examination:
| Finding | What It Means | Frequency |
|---|---|---|
| Heart failure signs | Pulmonary edema, elevated JVP | 20-30% |
| Murmurs | May have (mitral regurgitation) | 10-20% |
| Gallop rhythm | S3 (if heart failure) | 10-20% |
Signs of Complications:
Red Flags
[!CAUTION] Red Flags — Immediate Escalation Required:
- Severe chest pain — May indicate complications or other cause
- Signs of heart failure — Needs urgent treatment
- Cardiogenic shock — Medical emergency, needs ICU care
- Arrhythmias — May be life-threatening
- Signs of complications (thrombus, rupture) — Needs urgent treatment
Structured Approach: ABCDE
A - Airway
- Assessment: Usually patent
- Action: Secure if compromised
B - Breathing
- Look: May have difficulty breathing (if heart failure)
- Listen: May have crackles (pulmonary edema)
- Measure: SpO2 (may be low if heart failure)
- Action: Support if needed, oxygen if needed
C - Circulation
- Look: May have signs of heart failure (elevated JVP, peripheral edema)
- Feel: Pulse (may be irregular, fast), BP (may be low)
- Listen: Heart sounds (may have S3, murmurs)
- Measure: BP (may be low), HR (may be high)
- Action: Support if needed
D - Disability
- Assessment: Usually normal (may be anxious)
- Action: Assess if severe
E - Exposure
- Look: Cardiovascular examination
- Feel: JVP, peripheral pulses
- Action: Complete examination
Specific Examination Findings
Cardiovascular Examination:
- JVP: May be elevated (if heart failure)
- Heart sounds: May have S3 (if heart failure), murmurs (mitral regurgitation)
- Peripheral pulses: Usually normal (may be weak if shock)
- Peripheral edema: May have (if heart failure)
Respiratory Examination:
- Crackles: May have (if pulmonary edema)
- Wheeze: Usually not
Special Tests
| Test | Technique | Positive Finding | Clinical Use |
|---|---|---|---|
| ECG | 12-lead ECG | ST elevation, T wave changes | Mimics ACS |
| Echocardiography | Ultrasound of heart | Apical ballooning | Diagnostic |
| Troponin | Blood test | Elevated | Muscle damage |
First-Line (Bedside) - Do Immediately
1. ECG (Essential)
- Purpose: Shows changes (ST elevation, T wave changes)
- Finding: Mimics ACS (ST elevation, T wave inversion)
- Action: Essential for diagnosis
2. Troponin (Essential)
- Purpose: Shows muscle damage
- Finding: Elevated (but usually lower than typical MI)
- Action: Confirms muscle damage
Laboratory Tests
| Test | Expected Finding | Purpose |
|---|---|---|
| Troponin | Elevated (usually moderate) | Confirms muscle damage |
| BNP/NT-proBNP | Elevated (if heart failure) | Assesses heart failure |
| Full Blood Count | Usually normal | Baseline |
| Urea & Electrolytes | Usually normal | Baseline |
Imaging
Echocardiography (Essential):
| Indication | Finding | Clinical Note |
|---|---|---|
| All suspected cases | Apical ballooning, reduced ejection fraction | Diagnostic |
Findings:
- Apical ballooning: Characteristic "takotsubo" shape
- Reduced ejection fraction: Usually 20-40%
- Wall motion abnormalities: Apex hypokinetic/akinetic
Coronary Angiography (Essential to Rule Out ACS):
| Indication | Finding | Clinical Note |
|---|---|---|
| All suspected cases | No significant coronary artery disease | Rules out ACS, confirms takotsubo |
Findings:
- No significant blockages: Coronary arteries normal or minimal disease
- This is key: Differentiates from ACS
Cardiac MRI (If Needed):
| Indication | Finding | Clinical Note |
|---|---|---|
| Uncertain diagnosis | Apical ballooning, no late gadolinium enhancement | Confirms diagnosis |
Diagnostic Criteria
Clinical Diagnosis:
- Stress trigger + chest pain/ACS-like presentation + apical ballooning on echo + no significant CAD on angiography = Takotsubo cardiomyopathy
Mayo Clinic Criteria:
- Transient wall motion abnormalities (apical, mid-ventricular, basal, or focal)
- Absence of obstructive coronary disease or angiographic evidence of acute plaque rupture
- New ECG abnormalities or elevated troponin
- Absence of pheochromocytoma or myocarditis
Severity Assessment:
- Mild: Minimal symptoms, good function
- Moderate: Heart failure, needs treatment
- Severe: Cardiogenic shock, needs ICU care
Management Algorithm
SUSPECTED TAKOTSUBO
(Chest pain + stress + ACS-like)
↓
┌─────────────────────────────────────────────────┐
│ IMMEDIATE ASSESSMENT (ABCDE) │
│ • Airway, Breathing, Circulation │
│ • Treat as ACS until proven otherwise │
│ • Supportive care │
└─────────────────────────────────────────────────┘
↓
┌─────────────────────────────────────────────────┐
│ INVESTIGATIONS │
│ • ECG (ST elevation, T wave changes) │
│ • Troponin (elevated) │
│ • Echocardiography (apical ballooning) │
│ • Coronary angiography (rule out ACS) │
└─────────────────────────────────────────────────┘
↓
┌─────────────────────────────────────────────────┐
│ DIAGNOSIS CONFIRMED │
│ • Apical ballooning + no significant CAD │
│ • Supportive care │
│ • Treat heart failure if present │
└─────────────────────────────────────────────────┘
↓
┌─────────────────────────────────────────────────┐
│ HEART FAILURE TREATMENT │
│ • ACE inhibitor or ARB │
│ • Beta-blocker (when stable) │
│ • Diuretics (if fluid overload) │
│ • Monitor closely │
└─────────────────────────────────────────────────┘
↓
┌─────────────────────────────────────────────────┐
│ PREVENT COMPLICATIONS │
│ • Anticoagulation (prevent thrombus) │
│ • Monitor for arrhythmias │
│ • Monitor for recovery │
└─────────────────────────────────────────────────┘
↓
┌─────────────────────────────────────────────────┐
│ FOLLOW-UP │
│ • Repeat echo (monitor recovery) │
│ • Usually resolves within weeks to months │
│ • Long-term: Usually no treatment needed │
└─────────────────────────────────────────────────┘
Acute/Emergency Management - The First Hour
Immediate Actions (Do Simultaneously):
-
Treat as ACS Initially
- Dual antiplatelet therapy: Aspirin, clopidogrel
- Anticoagulation: If indicated
- Action: Until ACS ruled out
-
Supportive Care
- Oxygen: If needed
- IV access: Establish
- Monitoring: Continuous monitoring
- Action: Support organ function
-
Investigate
- ECG: Immediate
- Troponin: Immediate
- Echocardiography: As soon as possible
- Coronary angiography: To rule out ACS
- Action: Confirm diagnosis
-
Treat Heart Failure (If Present)
- Diuretics: If fluid overload
- ACE inhibitor: When stable
- Action: Support heart function
Medical Management
Heart Failure Treatment (If Present):
| Drug | Dose | Route | Duration | Notes |
|---|---|---|---|---|
| ACE inhibitor | As appropriate | Oral | Long-term | When stable |
| Beta-blocker | As appropriate | Oral | Long-term | When stable (avoid early) |
| Diuretics | Furosemide 40-80mg | IV/PO | As needed | If fluid overload |
Anticoagulation (Prevent Thrombus):
| Drug | Dose | Route | Duration | Notes |
|---|---|---|---|---|
| Aspirin | 75mg | Oral | Until recovery | Prevent thrombus |
| Anticoagulant | As appropriate | Oral | Until recovery | If high risk of thrombus |
Note: Anticoagulation controversial, but often used if high risk of thrombus
Avoid (Early):
- Beta-blockers early: May worsen (catecholamine surge)
- Inotropes: Usually not needed, may worsen
Disposition
Admit to Hospital:
- All cases: Need monitoring, investigation
- ICU: If cardiogenic shock or severe heart failure
Discharge Criteria:
- Stable: No complications
- Recovering: Function improving
- Clear plan: For follow-up
Follow-Up:
- Echocardiography: Repeat at 4-6 weeks (monitor recovery)
- Usually resolves: Within weeks to months
- Long-term: Usually no treatment needed once recovered
Immediate (Days-Weeks)
| Complication | Incidence | Presentation | Management |
|---|---|---|---|
| Heart failure | 20-30% | Pulmonary edema, elevated JVP | Diuretics, ACE inhibitor |
| Cardiogenic shock | 5-10% | Severe heart failure, hypotension | ICU care, inotropes if needed |
| Arrhythmias | 10-20% | Atrial fibrillation, VT | Treat as appropriate |
| Thrombus formation | 2-5% | May cause embolic events | Anticoagulation |
Heart Failure:
- Mechanism: Reduced ejection fraction
- Management: Diuretics, ACE inhibitor, supportive care
- Prevention: Early treatment
Cardiogenic Shock:
- Mechanism: Severe heart failure
- Management: ICU care, inotropes if needed
- Prevention: Early treatment, monitor closely
Early (Weeks-Months)
1. Persistent Dysfunction (5-10%)
- Mechanism: Incomplete recovery
- Management: Ongoing heart failure management
- Prevention: Early treatment
2. Recurrence (5-10%)
- Mechanism: Another stressor
- Management: Supportive care again
- Prevention: Stress management
Late (Months-Years)
1. Usually Full Recovery (90-95%)
- Mechanism: Reversible condition
- Management: Usually no long-term treatment needed
- Prevention: N/A
Natural History (Without Treatment)
Untreated Takotsubo:
- Most cases: Resolve spontaneously (weeks to months)
- Some cases: May have complications (heart failure, shock)
- Mortality: Low but can occur if complications
Outcomes with Treatment
| Variable | Outcome | Notes |
|---|---|---|
| Recovery | 90-95% | Most recover completely |
| Mortality | 1-5% | Low unless complications |
| Recurrence | 5-10% | Can recur with stress |
| Time to recovery | Weeks to months | Usually 4-8 weeks |
Factors Affecting Outcomes:
Good Prognosis:
- Early recognition: Better outcomes
- No complications: Better outcomes
- Younger age: May recover faster
- Mild cases: Usually recover completely
Poor Prognosis:
- Cardiogenic shock: Higher mortality
- Complications: Arrhythmias, thrombus worsen outcomes
- Older age: May have worse outcomes
- Recurrence: Can recur
Prognostic Factors
| Factor | Impact on Prognosis | Evidence Level |
|---|---|---|
| Early treatment | Better outcomes | High |
| Complications | Complications = worse | High |
| Age | Older = worse | Moderate |
| Severity | More severe = worse | Moderate |
Key Guidelines
1. ESC Guidelines (2016) — Takotsubo syndrome. European Society of Cardiology
Key Recommendations:
- Supportive care
- Treat heart failure
- Prevent complications
- Evidence Level: Expert opinion
Landmark Trials
Limited studies (relatively new condition, increasing recognition).
Evidence Strength
| Intervention | Level | Key Evidence | Clinical Recommendation |
|---|---|---|---|
| Supportive care | Expert opinion | Case series | Essential |
| Heart failure treatment | Expert opinion | Case series | If heart failure present |
| Anticoagulation | Expert opinion | Controversial | Consider if high risk |
What is Takotsubo Cardiomyopathy?
Takotsubo cardiomyopathy (also called "broken heart syndrome" or stress cardiomyopathy) is a temporary weakening of your heart muscle, usually triggered by severe emotional or physical stress. Think of your heart as a pump—when under extreme stress, part of your heart muscle temporarily stops contracting properly, causing your heart to balloon out. This can mimic a heart attack (chest pain, ECG changes), but it's caused by stress hormones rather than blocked arteries.
In simple terms: Your heart temporarily weakens due to severe stress, causing symptoms like a heart attack. The good news? It usually resolves completely within weeks to months, and most people make a full recovery.
Why does it matter?
Takotsubo can cause serious symptoms (chest pain, heart failure) and needs prompt treatment. However, unlike a heart attack, it usually resolves completely, and most people make a full recovery. Early recognition and treatment (supportive care, treating heart failure if present) can help you recover quickly.
Think of it like this: It's like your heart getting "stunned" by extreme stress—with the right care, it usually recovers completely.
How is it treated?
1. Supportive Care (Most Important):
- Hospital: You'll be admitted to hospital for monitoring
- Oxygen: If needed
- Rest: Rest helps your heart recover
- Monitoring: Close monitoring of your heart function
2. Treat Heart Failure (If Present):
- Medicines: You may need medicines to help your heart function (ACE inhibitors, diuretics)
- Why: To support your heart while it recovers
- Duration: Usually until your heart recovers
3. Prevent Complications:
- Anticoagulation: You may need blood thinners to prevent blood clots
- Monitor: Your doctor will monitor for complications (arrhythmias, etc.)
4. Recovery:
- Time: Your heart usually recovers within weeks to months
- Follow-up: You'll have follow-up tests (echocardiography) to monitor recovery
- Long-term: Usually no long-term treatment needed once recovered
The goal: Support your heart while it recovers from the stress, treat any complications, and help you get back to normal.
What to expect
Recovery:
- Hospital stay: Usually a few days to a week (depends on severity)
- Symptoms: Should start improving within days
- Heart function: Usually recovers within 4-8 weeks
- Full recovery: Most people make a full recovery
After Treatment:
- Medicines: You may need medicines temporarily (until your heart recovers)
- Follow-up: You'll have follow-up tests to monitor recovery
- Lifestyle: Stress management may help prevent recurrence
Recovery Time:
- Mild cases: Usually recover within weeks
- Moderate cases: Usually recover within weeks to months
- Severe cases: May take longer, but usually recover
When to seek help
Call 999 (or your emergency number) immediately if:
- You have severe chest pain
- You have difficulty breathing
- You feel very unwell
- You have symptoms that concern you
See your doctor if:
- You've had recent severe stress and have chest pain
- You have symptoms that concern you
- You have concerns about your heart
Remember: If you've had recent severe stress (emotional or physical) and develop chest pain or difficulty breathing, especially if you're a postmenopausal woman, see your doctor. Takotsubo can mimic a heart attack, so it's important to get checked. The good news? It usually resolves completely with proper care.
Primary Guidelines
- Lyon AR, Bossone E, Schneider B, et al. Current state of knowledge on Takotsubo syndrome: a Position Statement from the Taskforce on Takotsubo Syndrome of the Heart Failure Association of the European Society of Cardiology. Eur J Heart Fail. 2016;18(8):8-27. PMID: 27007100
Key Trials
- Limited studies (relatively new condition).
Further Resources
- ESC Guidelines: European Society of Cardiology
Last Reviewed: 2025-12-25 | MedVellum Editorial Team
Medical Disclaimer: MedVellum content is for educational purposes and clinical reference. Clinical decisions should account for individual patient circumstances. Always consult appropriate specialists. This information is not a substitute for professional medical advice, diagnosis, or treatment.